Search Results 581-590 of 17883 for monoclonal antibody
Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...
... antibody targeting B7-H3, to ... Received nitrosoureas less than 6 weeks or monoclonal antibodies less than 5 half-lives prior to the Screening Visit.
... monoclonal antibody, to decrease dose-reducing toxicities. In the phase 1 trial, researchers observed reduced markers of toxicities and no new safety issues ...
... monoclonal antibody that targets CD38, a protein found on the surface of myeloma cells, significantly reduces the risk of progression to active multiple ...
Most people start therapy that contains daratumumab (Darzalex), which is a monoclonal antibody used to treat multiple myeloma. ATTR therapies. Drugs such as ...
Monoclonal antibodies. This type of medicine works to block the action of certain proteins in the body that cause inflammation. A monoclonal antibody called ...
Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... Antibody-drug conjugates, such as lorvotuzumab mertansine, are ...
... Monoclonal Antibody F36/22 State University of New York at Buffalo; Research Affiliate - Diagnostic Immunology Research & Biochemistry Roswell Park Cancer ...
Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Drugs used in chemotherapy, such as ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!